Recruitment for Pharmaceutical Assessors

These exciting and interesting jobs put you at the heart of authorising animal medicines for the UK market.

You will assess quality data submitted in support of applications for the authorisation of pharmaceutical products and play a major role in assuring the quality and hence the safety and efficacy of animal medicines. You may manage and develop quality assessors in the Quality Team.

You will also contribute to the review and development of regulatory and scientific guidelines aimed at the pharmaceutical industry, contribute to the VMD’s Regulatory Science Strategy and play a significant role in the VMD’s international activities.

This work will significantly contribute to the VMD meeting its published standards.

Job Title

Pharmaceutical Assessor in the Pharmaceuticals/Quality Team


Grade 7


£52,289 – £60,188 per annum & Pension Scheme

Annual Leave entitlement

Commencing at 25 days

Regulatory Science Strategy and Guideline development role:

  • lead the Quality Team’s contribution to the VMD’s Regulatory Science Strategy and
  • lead the Quality Team’s contribution to developing scientific and regulatory industry guidance for pharmaceutical veterinary medicinal products

VMD international work role:

  • lead the co-ordination of the Quality Team’s contribution to VMD International Strategy activities

The main role of the team is to:

  • assess quality data submitted by companies in support of their applications for new marketing authorisations for veterinary medicines
  • consider applications to renew or vary existing authorisations
  • consider applications to conduct clinical trials and to deal with applications for feed additive authorisations


Applicants must have a degree or equivalent in pharmacy, pharmaceutical science, chemistry or other relevant subject.

How to apply

Pharmaceutical Assessors in the Pharmaceuticals/Quality Team – Civil Service Jobs – GOV.UK

Closing Date 7 February 2022

/Public Release. This material from the originating organization/author(s) may be of a point-in-time nature, edited for clarity, style and length. The views and opinions expressed are those of the author(s).View in full here.